Dividend Idea: A Medical Device Business Built Around Everyday Healthcare
A Medical Device Powerhouse With Surgical Scale And Consistent Innovation
⭐ Try the MaxDividends Research Platform →
The #1 Platform for Dividend Investors
Top Dividend Stocks & ETFs • Buy/Hold/Sell Ratings • Income Strategies • Member Insights • Dividend Tracker
A Medical Device Business Built Around Everyday Healthcare
Stryker (SYK)
When most people think about healthcare companies, they often think about drugmakers. Stryker is different.
The company makes many of the products hospitals and surgeons use every day. Its business includes orthopedic implants, surgical equipment, medical tools, neurotechnology products, and a wide range of devices used in operating rooms across the country.
What makes the business interesting is that it doesn’t rely on a single blockbuster product. Instead, Stryker is woven into many parts of the healthcare system. Hospitals continue performing surgeries, replacing equipment, and purchasing medical devices regardless of what happens in the broader economy. That creates a steady stream of demand that tends to repeat year after year.
For dividend investors, Stryker is not a high-yield stock. The current dividend yield sits at 1.17%, and the company pays $3.52 per share annually. However, the story here is not today’s income level. It’s the growth of that income over time.
Stryker has increased its dividend for 16 consecutive years. Even more notable, the dividend has grown by roughly 44% over the last five years.
The payout ratio remains around 41%, which means the company is still using less than half of its earnings to fund the dividend while retaining plenty of capital for new products, acquisitions, and business expansion.
The latest quarter showed that the business continues moving forward. First-quarter 2026 revenue reached $6.0 billion, while adjusted earnings came in at $2.60 per share. A cybersecurity incident during the quarter created some temporary disruption and affected the timing of certain sales, but management maintained its full-year outlook, suggesting that underlying demand remains intact.
Looking ahead, much of Stryker’s growth continues to come from areas where hospitals already spend significant amounts of money. New orthopedic products, surgical tools, medical equipment upgrades, and increasing procedure volumes all contribute to the company’s long-term growth strategy.
One of the advantages of this business is that hospitals typically don’t switch suppliers frequently. Surgeons become familiar with specific instruments and implant systems, staff are trained on certain equipment, and healthcare providers often prefer consistency. That creates long-term customer relationships and makes the business somewhat more predictable than many industries.
The business story is important. But for investors, the bigger question is whether the stock is worth buying today.
Is it attractively valued? How strong are the finances? Can dividend growth continue for years to come? And what signals should you watch if the story starts to change?
These are the questions we answer inside the MaxDividends Research Platform with simple ratings, dividend analysis, valuation tools, and clear buy, hold, and sell guidance.
⭐ Try the MaxDividends Research Platform →
The #1 Platform for Dividend Investors
Top Dividend Stocks & ETFs • Buy/Hold/Sell Ratings • Income Strategies • Member Insights • Dividend Tracker
MaxDividends Mission: Helping people build growing passive income, retire early, and live off dividends.